Fig. 5.
Fig. 5. Steady-state levels of HDC mRNA in the intradermal injection site tissue in the presence of RANTES (5, 10, and 20 ng/50 μL) lane 2, 3, and 4, respectively, and PBS (control) lane 1, and LPS 20 ng/50 μL (lane 5) after 4 hours of treatments. This is a representative experiment of four.

Steady-state levels of HDC mRNA in the intradermal injection site tissue in the presence of RANTES (5, 10, and 20 ng/50 μL) lane 2, 3, and 4, respectively, and PBS (control) lane 1, and LPS 20 ng/50 μL (lane 5) after 4 hours of treatments. This is a representative experiment of four.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal